A previous study also demonstrated the involvement of overexpression of LIN28A in the activation of the mTOR pathway indicating that inhibitors targeting the IGF/PI3K/mTOR pathway could be a promising novel treatment of ETMR [47]. This evidence concerns the gene IGF1 and ependymoblastoma.